Treatment of mild and moderate Covid19 ... Feb 14
Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the coronavirus that could enter human clinical trials in ... Jun 11
AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create ... Mar 13